Results 271 to 280 of about 177,645 (314)

Understanding the support dynamics for LGBTI+ youth in Spain during and after the COVID‐19 pandemic

Children &Society, EarlyView.
Abstract This qualitative study explores the experiences of LGBTI+ youth in Spain during the COVID‐19 pandemic, focusing on family, social, educational and healthcare support mechanisms. The findings, based on five focus groups, highlight the pivotal role of family support during the pandemic, increased isolation and a reliance on online connections ...
Lucas Platero, Elena Gallardo‐Nieto, Irene Blanco‐Fuente, Miguel Ángel López‐Sáez   +3 more
wiley   +1 more source

Threshold effect of visceral adiposity index on suicidal ideation: a mediation analysis through fasting blood glucose. [PDF]

Front Psychiatry
Zhang L, Zhang W, Hang L.
europepmc   +1 more source

Interaction of Child Maltreatment and 5-HTT Polymorphisms: Suicidal Ideation among Children from low-SES Backgrounds

, 2009
Dante Cicchetti, Fred A. Rogosch, Melissa L. Sturge‐Apple, Sheree L. Toth   +3 more
openalex   +1 more source

Insomnia, Social Disconnectedness, and Suicidal Ideation Severity in Underserved Veterans. [PDF]

Cognit Ther Res
Boffa JW, Raines AM, Franklin CL, Beckham JC, Stecker T.   +4 more
europepmc   +1 more source

Analysis of trichoscopic images using deep neural networks for the diagnosis and activity assessment of alopecia areata – a retrospective study

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and objectives Alopecia areata (AA) is an autoimmune disease that provokes hair loss. The diagnosis is made clinically with the support of trichoscopy. However, trichoscopy requires specialized training. Deep learning models may support the diagnosis and management of AA.
Raffaele Dante Caposiena Caro, Victoria Orlova, Nicola Di Meo, Iris Zalaudek   +3 more
wiley   +1 more source

Relative efficacy of GLP‐1 and GLP‐1/GIP receptor agonists in the prevention of alcohol‐use disorders using a target trial emulation approach

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims There is growing evidence that the GLP‐1 system is implicated in alcohol and other substance use disorders, and that GLP‐1‐based therapies may have therapeutic relevance in alcohol use disorder (AUD). We aimed to determine the impact of GLP‐1 based therapies on incident AUDs in a real‐world setting in patients with T2D.
Alex E. Henney, David R. Riley, Megan Heague, Carl A. Roberts, Theresa J. Hydes, Matthew Anson, David M. Hughes, Uazman Alam, Daniel J. Cuthbertson   +8 more
wiley   +1 more source

Psychiatric effects of GLP‐1 receptor agonists: A systematic review of emerging evidence

Diabetes, Obesity and Metabolism, EarlyView.
Abstract This systematic review examines the current literature on glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs)‐associated psychiatric manifestations, including depression, suicidality, eating disorders, substance use disorders (SUD) and schizophrenia spectrum disorders.
Brianna Sa, Anthony Maristany, Ashwin Subramaniam, Ryan Guillen, Brooke Buonocore, Audrey Smith, Sean E. Oldak, Vanessa Padilla   +7 more
wiley   +1 more source

Clinical research updates

Child and Adolescent Mental Health, EarlyView.
Marinos Kyriakopoulos, Athanasios Beladonas, Dimitrios Lappas, Spyridoula Kyriakopoulou   +3 more
wiley   +1 more source

Weight‐reducing treatments are associated with an improvement in depression, functional health status, and quality of life: A meta‐analysis of randomized controlled trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aim To assess whether there is a beneficial or detrimental effect of weight reduction on mental health. Materials and methods Meta‐analysis of randomized trials performed for weight loss, in which weight loss at endpoint was greater than 5% in the intervention arm and smaller than 5% in the control arm, obtained with any surgical, endoscopic ...
Giovanni Antonio Silverii, Matteo Monami, Francesco Rotella, Maurizio De Luca, Tommaso Viozzi, Rocco Barazzoni, Silvio Buscemi, Luca Busetto, Paolo Sbraccia, Edoardo Mannucci   +9 more
wiley   +1 more source

Retatrutide for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Retatrutide, a novel synthetic molecule, is a triple agonist activating the glucose‐dependent insulinotropic polypeptide, glucagon‐like peptide‐1 and glucagon receptors. The TRIUMPH clinical development program evaluates its safety and efficacy concurrently for the treatment of obesity and two related complications—obstructive sleep apnea
Kathryn Giblin, Lee M. Kaplan, Virend K. Somers, Carel W. Le Roux, David J. Hunter, Qiwei Wu, Amy Lalonde, Nadia Ahmad, Mary Angelyn Bethel   +8 more
wiley   +1 more source